trial · primary record
Biopsy
Prostate Adenocarcinoma
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 50 |
| Primary completion | 2032-11-19 |
| Primary endpoint | Pathologic response (biopsy positivity rate) |
| Registry ID | NCT06499870 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:45:05.128Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06499870
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Biopsy · compound